MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4962 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-04-17 (longportapp.com)
Tariff clouds loom large! Barclays names the "pressure-resistant king" and "disaster area" in the US medical device industry
Barclays Bank analyzed the impact of the new tariff policy of the Trump administration on the medical device industry in its research report. The report pointed out that Abbott and Baxter International will be the least affected companies, while Johnson & Johnson and Medtronic will be the most affected. Among large medical technology companies, Abbott, Baxter International, Edwards Lifesciences, and Intuitive Surgical were rated as "buy," while Zimmer Biomet Holdings was rated as "sell." Small and mid-cap stocks such as Globus Medical, AlphaTek, and Tandem Diabetes Care are also less affected. In contrast, companies like Becton Dickinson, InMode, and Medtronic face significant tariff risks
Read more
2025-04-16 (jhconline.com)
Tariffs top of mind for medtech firms this earnings season – The Journal of Healthcare Contracting
April 17, 2025- Tariffs from U.S. President Donald Trump have plunged the country into trade wars abroad, with on-again, off again levies escalating uncertainty, according to AP News. As President Donald Trump's tariff policies continue to evolve, medtech investors will be focused on companies' plans to manage the impact on supply chains when they tune into first-quarter earnings calls starting this week, according to MedTech Dive. The tariff plans have brought concerns across industries about the repercussions for global trade. GE Healthcare and Medtronic were among more than 20 U.S. companies that participated in a roundtable meeting last week with China's Ministry of Commerce.
Read more
2025-04-14 (medtechdive.com)
Tariffs top of mind for medtech firms this earnings season |
GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump's tariff policies.
Read more
2025-04-04 (forbes.com)
Trump's Tariffs Could Raise The Price Of Pacemakers And Insulin Pumps
With no exemptions for medical devices from Trump's double-digit tariffs, pacemakers, insulin pumps and hearing aids could all cost more.
Read more